A phase I study to evaluate an investigational medicinal product for the treatment of asthma, in healthy adult participants.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504326-19-00

Acronym

CLI-00718AA2-02

Enrollment

Registered

2023-07-19

Start date

2023-08-03

Completion date

2023-12-15

Last updated

2024-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026